Image (Ec6939e2 4f64 4edd 848c 83e73ffac433 01)
Eltrombopag Olamine Tablet, Film Coated
Product Images NDC 70069-839
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag Olamine (NDC 70069-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Ec6939e2 4f64 4edd 848c 83e73ffac433 02)
This text provides important information about a medication with NDC number 70069-837-01. It advises to store the medication at room temperature between 20°C to 25°C (68°F to 77°F) and mentions the manufacturer as Somerset Therapeutics, LLC. The medication is an Eltrombopag tablet made in Spain, with dosage information available in the accompanying prescribing information. It also emphasizes the importance of keeping the medication out of the reach of children and provides a warning not to split, chew, or crush the tablets.*
Image (Ec6939e2 4f64 4edd 848c 83e73ffac433 03)
This is a medication description for Eltrombopag tablets, which are only available by prescription. It is important to swallow the tablets whole and not split, chew, or crush them. The tablets should be stored at room temperature. Each tablet contains 25 mg of Eltrombopag. It is essential to keep this medication out of the reach of children and to use safety closures when dispensing. For more detailed dosage information, refer to the accompanying Prescribing Information. The medication is manufactured by Somerset Therapeutics, LLC and has a QR code for access to the Medication Guide.*
Image (Ec6939e2 4f64 4edd 848c 83e73ffac433 04)
This is a description for Eltrombopag tablets, a medication that should be swallowed whole and not split, chewed, or crushed. It is advisable to dispense with the Medication Guide attached. The tablets should be stored at room temperature, and dosage information can be found in the accompanying Prescribing Information. Safety closures should be used when dispensing, and the product should be kept out of the reach of children. Each tablet contains eltrombopag olamine equivalent to 50 mg of eltrombopag free acid. The tablets are manufactured by Somerset Therapeutics in Spain.*
Image (Ec6939e2 4f64 4edd 848c 83e73ffac433 05)
This text provides instructions for Elmironbopag tablets, advising to swallow them whole without splitting, chewing, or crushing. The tablets contain eltrombopag olamine equivalent to 75 mg of eltrombopag free acid. It also includes storage recommendations, dosage information, and safety precautions. The medication is manufactured by Somerset Therapeutics, LLC, in Spain. A QR code for the Medication Guide is provided as well.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
